There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.








With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop.


Table of Contents


Front Matter
1 Introduction
2 Integrating Community Practice and Clinical Trials
3 Improving Public Participation in Clinical Trials
4 Creating a New Business Model for Clinical Trials
5 Building an Infrastructure to Support Clinical Trials
6 Suggesting an Agenda for Transforming Elements of the Clinical
Trials Enterprise
References
Appendix A: Workshop Agenda
Appendix B: Participant Biographies
Appendix C: Registered Workshop Attendees
Appendix D: Discussion Paper: The Clinical Trials Enterprise in the
United States: A Call for Disruptive Innovation
Appendix E: Discussion Paper: Developing a Robust Clinical Trials
Workforce
Appendix F: Discussion Paper: Transforming the Economics of
Clinical Trials
Appendix G: Discussion Paper: Developing a Clinical Trials
Infrastructure
Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented
Research
Appendix I: Discussion Paper: Health Research as a Public Good
Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data:
The UK Experience
Appendix K: IOM Staff Paper: Context and Glossary of Select Terms
Associated with the Clinical Trials Enterprise